- Home
- FBRT vs MDXG Comparison
FBRT vs MDXG Comparison
Compare FBRT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | MDXG |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | 223 | 808 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 648.8M | 607.7M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | FBRT | MDXG |
|---|---|---|
| Price | $8.17 | $4.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $11.50 | $9.00 |
| AVG Volume (30 Days) | ★ 1.2M | 1.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $12.34 | N/A |
| Revenue Next Year | $4.95 | $13.02 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $7.75 | $3.03 |
| 52 Week High | $11.84 | $7.99 |
Technical Indicators
Market Signals| Indicator | FBRT | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 48.63 | 64.40 |
| Support Level | N/A | $3.50 |
| Resistance Level | $8.51 | $5.38 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 60.43 | 77.78 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.